Find out how you can accelerate NASH drug testing leveraging InSphero's 3D InSight™ services.
NASH Drug Testing: Assess mechanisms of NASH induction and efficacy of NASH drugs
NASH Drug Testing : The 3D InSight™ Human Liver NASH Model ideal for the study of mechanisms of non-alcoholic steatohepatitis (NASH) induction and in vitro screening of NASH drug discovery.
Because this advanced model includes all the critical liver cells and inducers needed to recapitulate the inflamed fatty liver disease state, it is a powerful model for NASH drug discovery and development.
Our liver platform services team will work with you to design and implement a custom study package tailored to your research needs, and select the most appropriate endpoints for your experimental program.
InSphero sets the standard for 3D cell culture in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision-making.
Our suite of3D InSight™ Platforms and Services is used by major biopharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing.
Our patented technologies and models enable the scalable production of scaffold-free 3D organoids driven solely by cellular self-assembly.
InSphero specializes in delivering assay-ready and custom 3D models derived from liver, pancreatic islet, and tumor tissues, to provide unrivaled biological insight into liver toxicology, metabolic diseases, and oncology.
All InSphero microtissues are validated to ensure the highest quality and certified for use in multiple assays.
InSphero's 3D spheroids are shipped globally in a patented, spheroid-optimized format, ready for research.